A Masterclass in Innovation and Execution with Dr. Hernan Bazan

In this episode, Jeff sits down with Dr. Hernan Bazan, a vascular surgeon, biotech entrepreneur, and CEO of South Rampart Pharma, to explore a groundbreaking approach to pain management and drug development. Dr. Bazan shares his journey from the operating room to leading a life sciences company, discussing the unique approach his team has taken to develop SRP-001, a novel, non-opioid pain treatment that has received FDA fast-track designation. Throughout the conversation, Dr. Bazan highlights how his dual perspective as a practicing physician and a biotech leader allows him to challenge the traditional drug development model. He dives into the importance of capital efficiency, leveraging NIH funding, and assembling a world-class team without the typical overhead of a life sciences company. He also reflects on his leadership philosophy, emphasizing that leadership is relationships and that true execution requires understanding every aspect of the business—not just delegating. Jeff and Dr. Bazan discuss the broader landscape of pain management, the growing investor and regulatory interest in alternatives to opioids, and what it takes for clinicians with innovative ideas to turn them into reality. The episode is a must-listen for anyone in the life sciences space looking to rethink execution, funding, and leadership in biotech. Key Takeaways: 🔹 How Dr. Bazan transitioned from vascular surgery to biotech innovation 🔹 The unique, capital-efficient model South Rampart Pharma is using to develop new drugs 🔹 Why having a practicing physician’s perspective is valuable in biotech 🔹 The importance of relationships in leadership and execution 🔹 The growing momentum in the pain management space and what it means for investors 🔹 Advice for clinicians and scientists looking to bring new medical innovations to market Resources & Links: 🔗 Learn more about South Rampart Pharma: www.southrampartpharma.com 🔗 Follow South Rampart Pharma on LinkedIn - https://www.linkedin.com/company/south-rampart-pharma-llc/ 🔗 Read the latest coverage in BioSpace - https://www.biospace.com/drug-development/vertexs-journavx-changes-the-pain-treatment-landscape-but-opioids-here-to-stay Dr. Bazan’s insights provide a mini-masterclass in executing innovation in biotech. If you're an entrepreneur, investor, or clinician with an idea, this episode will challenge you to think differently about leadership, funding, and bringing novel treatments to patients.